AorTech International PLC New Patent (9873N)
27 May 2020 - 4:00PM
UK Regulatory
TIDMAOR
RNS Number : 9873N
AorTech International PLC
27 May 2020
AorTech International plc
("AorTech" or the "Company")
New Patent
AorTech International plc (AIM: AOR.L), the holding company of a
group of medical device businesses focused on the exploitation of
the world's leading long-term implantable biostable polymer
(Elast-Eon (TM) ), is pleased to announce that the United States
Patent and Trademark Office has notified AorTech that its
Application Number 15/995,050 will issue as Patent Number
10,676,560 entitled "BIOSTABLE POLYURETHANES" on 9th June 2020.
The invention relates to a biostable polyurethane or polyurea
comprising: (a) a soft segment comprising a polysiloxane of the
general formula disclosed in the Patent; and (b) greater than 0 and
less than 40 wt % of a hard segment which is a reaction product of
a diisocyanate and a linear difunctional chain extender, processes
for their preparation and their use in the manufacture of
biomaterials, implantable medical devices and polymeric heart
valves.
Bill Brown, Chairman of AorTech, said : "We are delighted that
at the same time as major steps are being made in the development
of our ElastEon (TM) enabled medical devices, our Intellectual
Property portfolio relating to the ElastEon(TM) family of world
class biostable polymers has been expanded further by the grant of
this latest US patent. We currently anticipate reaching the
significant milestone of commencing animal testing on the ElastEon
(TM) sealed graft in the coming weeks."
For further information contact:
AorTech International plc
Bill Brown, Chairman Tel: +44 (0) 77 3071 8296
David Richmond, CEO Tel: +44 (0) 78 9999 6400
Shore Capital
Tom Griffiths/David Coaten Tel: +44 (0)20 7408 4080
About AorTech
AorTech has developed biostable, implantable polymers, including
Elast-Eon(TM) and ECSil(TM), now manufactured on its behalf by
Biomerics LLC in Utah, USA. Elast-Eon(TM) and ECSil(TM)'s
biostability is comparable to silicone while exhibiting excellent
mechanical, blood contacting and flex-fatigue properties. These
polymers can be processed using conventional thermoplastic
extrusion and moulding techniques. With over 6 million implants and
over 10 years of successful clinical use, AorTech polymers are
proven in long term life enabling applications.
In addition to continuing to exploit AorTech's Intellectual
Property related to the world class biomaterial - Elast-Eon(TM),
AorTech is now incorporating this material into a number of medical
devices of our own design. Elast-Eon(TM) has first class long term
blood contacting properties and, as a result, all of the initial
products being developed are for the cardio vascular field. Each
device is being designed to have improved clinical outcomes over
current device technology, eliminating the use of animal sourced
material whilst allowing procedures to remain the same, therefore
avoiding having to retrain surgeons in new ways of operating.
About RUA Medical Devices
RUA Medical is an experienced full-service medical device
contract developer, contract manufacturer and implantable fabric
specialist. The company provides subcontract design, development,
manufacture, assembly, packing, inventory management, logistics and
consultancy services to the Medical Device and Biotech Industries.
The company partners with globally based companies to provide
technologically innovative products that can deliver lifesaving and
life enhancing solutions, and focuses on personalised service,
combined with innovative design and development.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCDZGZKVVDGGZM
(END) Dow Jones Newswires
May 27, 2020 02:00 ET (06:00 GMT)
Rua Life Sciences (LSE:RUA)
Historical Stock Chart
From Apr 2024 to May 2024
Rua Life Sciences (LSE:RUA)
Historical Stock Chart
From May 2023 to May 2024